Freeline Announces First Patient Dosed with Its Novel Gene T

Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson's Disease

Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson's Disease

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Italy , London , City Of , United Kingdom , Germany , Spain , France , Israel , Pamela Foulds , Naomi Aoki , Ozlem Goker Alpan , Michael Parini , Exchange Commission , Nasdaq , Treatment Center , Freeline Therapeutics Holdings , Head Of Investor Relations Corporate Communications , Research Program , Rare Disorder Research , Company Annual Report On Form , Company Gcase , Announces First Patient Dosed , Its Novel Gene Therapy Candidate , Gaucher Disease , Unveils Research Program , Therapeutics Holdings , Chief Medical Officer , Chief Executive Officer , Annual Report , Statement Regarding Forward Looking , Investor Contact , Vice President , Investor Relations ,